Scarica l'app Stockscreener
330.42
1.70%
-5.70
Pre-mercato:
329.00
-1.42
-0.43%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$336.12
Aprire:
$336.44
Volume 24 ore:
303.09K
Relative Volume:
1.21
Capitalizzazione di mercato:
$7.27B
Reddito:
$2.58B
Utile/perdita netta:
$-778.69M
Rapporto P/E:
-12.09
EPS:
-27.33
Flusso di cassa netto:
$223.75M
1 W Prestazione:
-0.26%
1M Prestazione:
+21.76%
6M Prestazione:
+37.58%
1 anno Prestazione:
+0.56%
Intervallo 1D:
$327.40
$340.68
Intervallo di 1 settimana:
$326.63
$343.12
Portata 52W:
$211.43
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Nome
Bio Rad Laboratories Inc
Settore
Industria
Telefono
(510) 724-7000
Indirizzo
1000 ALFRED NOBEL DRIVE, HERCULES
Confronta BIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
330.42 | 9.10B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
126.61 | 221.35B | 43.84B | 13.94B | 6.78B | 7.9979 |
|
BSX
Boston Scientific Corp
|
100.97 | 151.78B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
375.93 | 146.70B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
93.23 | 120.73B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.19 | 47.45B | 5.69B | 1.41B | 577.90M | 6.9828 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-03 | Downgrade | Citigroup | Buy → Neutral |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-06-16 | Iniziato | Wells Fargo | Overweight |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-01-28 | Reiterato | Citigroup | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2018-10-17 | Iniziato | Goldman | Buy |
| 2018-09-20 | Iniziato | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Downgrade | CL King | Buy → Neutral |
| 2017-07-13 | Iniziato | Wells Fargo | Outperform |
| 2017-06-28 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Hold |
| 2016-10-13 | Iniziato | CL King | Buy |
| 2015-05-06 | Reiterato | Jefferies | Buy |
| 2009-12-18 | Iniziato | Maxim Group | Buy |
| 2009-11-06 | Iniziato | Jefferies & Co | Buy |
| 2009-07-17 | Iniziato | Soleil | Buy |
| 2007-09-26 | Iniziato | Banc of America Sec | Buy |
| 2007-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
Bio Rad Laboratories Inc Borsa (BIO) Ultime notizie
Rising Trends of Malaria Diagnostics Market: Emerging - openPR.com
Bio Rad Laboratories Inc BUWA Stock Analysis and ForecastMarket Sentiment Shifts & Free Tremendous Growth Opportunities - earlytimes.in
Lyme Disease Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Abbott, Bio-Rad Laboratories, Inc., Covance Inc.F. Hoffmann-La Roche AG - Barchart.com
Will Bio Rad Laboratories Inc. stock split attract more investors2025 Volume Leaders & Momentum Based Trading Ideas - Fundação Cultural do Pará
What to Expect from Bio-Rad Laboratories Inc (BIO) Q3 2025 Earni - GuruFocus
Is Bio Rad Laboratories Inc. stock a bargain at current levelsBull Run & Free Expert Approved Momentum Trade Ideas - newser.com
Will Bio Rad Laboratories Inc. (BUW) stock attract long term capital inflowsTrade Risk Assessment & Fast Gain Stock Tips - newser.com
How to manage a losing position in Bio Rad Laboratories Inc.Weekly Trade Summary & Weekly Stock Performance Updates - newser.com
How Bio Rad Laboratories Inc. (BUW) stock stacks up against competitorsPortfolio Update Report & Stepwise Entry/Exit Trade Alerts - newser.com
Understanding Bio Rad Laboratories Inc.’s price movementEarnings Growth Summary & Technical Buy Zone Confirmations - newser.com
What recovery options are there for Bio Rad Laboratories Inc.2025 Investor Takeaways & Consistent Growth Stock Picks - newser.com
What technical charts say about Bio Rad Laboratories Inc. stockMarket Volume Report & Daily Entry Point Trade Alerts - newser.com
Why analysts raise outlook for Bio Rad Laboratories Inc. Class B stockJuly 2025 Update & Entry and Exit Point Strategies - Fundação Cultural do Pará
Is Bio Rad Laboratories Inc. stock poised for growthWeekly Trend Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Will Bio Rad Laboratories Inc. stock recover after recent dropJuly 2025 Price Swings & Verified Entry Point Signals - newser.com
Using R and stats models for Bio Rad Laboratories Inc. forecastingTrade Signal Summary & Intraday High Probability Alerts - newser.com
Will Bio Rad Laboratories Inc. stock see insider buying2025 Biggest Moves & Verified Technical Trade Signals - Fundação Cultural do Pará
Bio Rad Laboratories Inc. stock trend forecastJuly 2025 Earnings & Low Risk Entry Point Guides - newser.com
How Bio Rad Laboratories Inc. Class B stock responds to bond marketGlobal Markets & AI Enhanced Trading Alerts - newser.com
Is Bio Rad Laboratories Inc. forming a bottoming baseJuly 2025 Drop Watch & AI Optimized Trading Strategy Guides - newser.com
Will Bio Rad Laboratories Inc. outperform the marketTrade Exit Report & Safe Capital Growth Plans - newser.com
What macro factors could drive Bio Rad Laboratories Inc. Class stock higherWall Street Watch & Low Risk High Reward Ideas - newser.com
Earnings Risk: How geopolitical risks impact Bio Rad Laboratories Inc. (BUW) stock2025 Institutional Moves & Consistent Growth Equity Picks - Fundação Cultural do Pará
Will Bio Rad Laboratories Inc. Class stock outperform value peersJuly 2025 Movers & Breakout Confirmation Trade Signals - newser.com
How strong is Bio Rad Laboratories Inc. stock balance sheetEarnings Beat & Stock Portfolio Risk Control - newser.com
Is Bio Rad Laboratories Inc. (BUWA) stock a top hedge fund pickJuly 2025 Technicals & Real-Time Volume Analysis Alerts - newser.com
What drives Bio Rad Laboratories Inc stock priceStock Correlation Metrics & Free Powerful Profit Generation - earlytimes.in
How Bio Rad Laboratories Inc. (BUW) stock reacts to weak economyRate Cut & Safe Capital Growth Stock Tips - newser.com
Why global investors buy Bio Rad Laboratories Inc. (BUWA) stockWeekly Stock Summary & Consistent Growth Equity Picks - newser.com
What valuation ratios show for Bio Rad Laboratories Inc. Class stockEarnings Overview Summary & Momentum Based Trading Signals - newser.com
Bio-Rad Laboratories Adjusts Valuation Amidst Financial Performance Challenges and Market Reassessment - Markets Mojo
Biodesix Expands Bio-Rad Partnership in Cancer Diagnostics - Technology Networks
Can Bio Rad Laboratories Inc. stock sustain revenue growthStop Loss & Daily Entry Point Trade Alerts - newser.com
Is Bio Rad Laboratories Inc. (BUWA) stock protected from inflationPortfolio Performance Summary & AI Forecasted Entry/Exit Points - newser.com
Is Bio Rad Laboratories Inc. meeting your algorithmic filter criteria2025 Retail Activity & Verified Entry Point Signals - newser.com
United States Gene Transfer Technologies Market 2025: Industry - openPR.com
Does Bio Rad Laboratories Inc. qualify in momentum factor screeningIndex Update & Long-Term Growth Plans - newser.com
What market sentiment indicators show for Bio Rad Laboratories Inc. (BUWA) stockBear Alert & Momentum Based Trading Signals - newser.com
United States Life Science Instruments and Consumables Market - openPR.com
What valuation multiples suggest for Bio Rad Laboratories Inc. stockJuly 2025 Reactions & Intraday High Probability Setup Alerts - newser.com
Bio Rad Laboratories Inc Azioni (BIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.45%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):